Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation

SIMPLE SUMMARY: In recent decades, scientific discoveries brought up several new treatments and improvements for patients suffering from hepatocellular carcinoma (HCC). However, increasing resistance to current therapies, such as sorafenib, worsen the outcome of HCC patients, leading to a search for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekric, Dino, Ocker, Matthias, Mayr, Christian, Stintzing, Sebastian, Ritter, Markus, Kiesslich, Tobias, Neureiter, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998032/
https://www.ncbi.nlm.nih.gov/pubmed/35406596
http://dx.doi.org/10.3390/cancers14071826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998032/
https://www.ncbi.nlm.nih.gov/pubmed/35406596
http://dx.doi.org/10.3390/cancers14071826

Ejemplares similares